Is Summit Therapeutics Inc. stock a buy or sell right now?

Based on current indicators, Summit Therapeutics Inc. shows a Sell signal, with bearish momentum and trend strength favoring downside.

What is Summit Therapeutics Inc.’s RSI?

RSI is 41.31, showing balanced momentum within the normal range.

What does MACD indicate for SMMT?

MACD at -0.92 shows bearish pressure, with downside momentum building.

What are Summit Therapeutics Inc.’s key support and resistance levels?

Support sits around $12.17, while resistance is near $17.30.

Summit Therapeutics Inc. (SMMT) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Summit Therapeutics Inc..

SMMT●NASDAQ

HealthcareBiotechnology

$14.25

$0.00(0.00%)

U.S. Market opens in 7h 41m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

SMMT Technical Analysis Summary

Summit Therapeutics Inc. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral

Momentum:Neutral to Bearish (RSI: 41.31)

Trend Strength:Moderate (ADX: 26.47)

Volatility:High (ATR: 1.03)

Support/Resistance:$12.17 – $17.30 (Bollinger Bands)

Overall, Summit Therapeutics Inc. remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 41.31

Bearish

Below midpoint indicates downward pressure.

Stochastic %K: 59.64

Neutral

Mid-range signal with no clear trend.

Williams %R: -39.64

Bullish

Buying pressure building steadily.

Rate of Change (ROC): -5.51

Strongly Bearish

Sharp downside momentum.

Takeaway:Summit Therapeutics Inc. shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: -0.92

Bearish

Bearish, trend momentum is strengthening to the downside.

ADX: 26.47

Moderate

Moderate trend, direction gaining strength.

ATR (14): 1.03

Low

Low volatility, stable price action.

CCI (14): 51.85

Bullish

Bullish, momentum building upward.

Takeaway:Summit Therapeutics Inc. shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators

Bollinger Bands

Upper Band

$17.30

Middle Band (SMA 20)

$14.74

Lower Band

$12.17

Current Position

Within Bands

Takeaway:Summit Therapeutics Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels

Upper Channel

$16.89

Middle Line (EMA 20)

$14.82

Lower Channel

$12.75

Squeeze Status

No Squeeze

Takeaway:Summit Therapeutics Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis

On-Balance Volume-8.05M

Money Flow Index71.68Bullish, inflows support continued momentum.

Relative Vigor Index45.93Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:SMMT shows mixed signals in money flow analysis.

Technical Trading Signals Summary

Based on the current technical analysis of Summit Therapeutics Inc., here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Summit Therapeutics Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.